Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Leukocyte activation inhibitor active in animal models of myocardial infarction

April 6, 1998

Prostate cancer immunotherapeutic evaluated in preclinical and clinical trials

April 6, 1998

RS-100975, a prostate-selective alpha-blocker in vitro

April 6, 1998

The alpha1L-adrenoceptor: a new target for BPH therapy

April 6, 1998

Orally active thrombin inhibitor discovered at Pfizer shows good tolerance in phase I

April 6, 1998

Selective PDE IV/TNF-alpha inhibitors focus of research at Yamanouchi

April 6, 1998

Highly potent GH secretatogues discovered by Merck & Co.

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...